Diversity, Equity, and Inclusion in Colorectal Cancer Treatment

Renee Williams, MD, MHPE


May 24, 2023

Colorectal cancer screening, treatment, and mortality outcomes vary widely according to ethnicity, but non-Hispanic Black men and American Indian or Native Alaskan men face the greatest risks for poor outcomes.

In this ReCAP, Dr Renee Williams from NYU Langone Health in New York City discusses incorporating recognition of issues of diversity, equity, and inclusion across the continuum of colorectal cancer care.

She explains how "redlining," the historical practice of restricting services to specific neighborhoods, negatively influenced social determinants of health, which are linked to outcomes.

Dr Williams explains how clinicians can combat this by being sensitive to patients' social determinants of health, such as food insecurity and transportation barriers.

She recommends practicing cultural humility when addressing patients' health literacy and including their families in discussions of treatment options. Finally, Dr Williams outlines how advocating for patients at the policy level can reduce racial disparities.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.